DihydrocatalpolCAS# 6736-86-3 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 6736-86-3 | SDF | Download SDF |
PubChem ID | 5705531.0 | Appearance | Powder |
Formula | C15H24O10 | M.Wt | 364.35 |
Type of Compound | Iridoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2S,3R,4S,5S,6R)-2-[[(1S,2S,4S,5S,6R,10S)-5-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.02,4]decan-10-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol | ||
SMILES | C1COC(C2C1C(C3C2(O3)CO)O)OC4C(C(C(C(O4)CO)O)O)O | ||
Standard InChIKey | NYCXYIWXBJWWIL-PZYDOOQISA-N | ||
Standard InChI | InChI=1S/C15H24O10/c16-3-6-9(19)10(20)11(21)14(23-6)24-13-7-5(1-2-22-13)8(18)12-15(7,4-17)25-12/h5-14,16-21H,1-4H2/t5-,6-,7-,8+,9-,10+,11-,12+,13+,14+,15-/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Dihydrocatalpol Dilution Calculator
Dihydrocatalpol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.7446 mL | 13.7231 mL | 27.4461 mL | 54.8923 mL | 68.6153 mL |
5 mM | 0.5489 mL | 2.7446 mL | 5.4892 mL | 10.9785 mL | 13.7231 mL |
10 mM | 0.2745 mL | 1.3723 mL | 2.7446 mL | 5.4892 mL | 6.8615 mL |
50 mM | 0.0549 mL | 0.2745 mL | 0.5489 mL | 1.0978 mL | 1.3723 mL |
100 mM | 0.0274 mL | 0.1372 mL | 0.2745 mL | 0.5489 mL | 0.6862 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Isobellidifolin
Catalog No.:BCX1286
CAS No.:552-00-1
- Napelline
Catalog No.:BCX1285
CAS No.:5008-52-6
- Morusignin L
Catalog No.:BCX1284
CAS No.:149733-95-9
- 5-Hydroxy-3,7-dimethoxyflavone
Catalog No.:BCX1283
CAS No.:70786-48-0
- 1-(2,6-Dimethoxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one
Catalog No.:BCX1282
CAS No.:85679-87-4
- Ethyl rosmarinate
Catalog No.:BCX1281
CAS No.:174591-47-0
- 3,5,7-Trimethoxyflavone
Catalog No.:BCX1280
CAS No.:26964-29-4
- Micromarin F
Catalog No.:BCX1279
CAS No.:73292-93-0
- Palvanil
Catalog No.:BCX1278
CAS No.:69693-13-6
- N-Acetylcytisine
Catalog No.:BCX1277
CAS No.:6018-52-6
- Hispidol
Catalog No.:BCX1276
CAS No.:5786-54-9
- 2',4,4',6'-Tetramethoxychalcone
Catalog No.:BCX1275
CAS No.:94103-36-3
- Ajugose
Catalog No.:BCX1288
CAS No.:512-72-1
- Limocitrin 3-O-β-D-glucopyranoside
Catalog No.:BCX1289
CAS No.:38836-51-0
- Wistin
Catalog No.:BCX1290
CAS No.:19046-26-5
- Physcion-8-O-β-gentiobioside
Catalog No.:BCX1291
CAS No.:84268-38-2
- Chaparrinone
Catalog No.:BCX1292
CAS No.:22611-34-3
- Ajugasterone C 2-acetate
Catalog No.:BCX1293
CAS No.:154510-93-7
- t-OMe-Byakangelicin
Catalog No.:BCX1294
CAS No.:79638-04-3
- Amaroswerin
Catalog No.:BCX1295
CAS No.:21233-18-1
- Hypoglaunine D
Catalog No.:BCX1296
CAS No.:220751-00-8
- Kanshone C
Catalog No.:BCX1297
CAS No.:117634-64-7
- Lyciumin A
Catalog No.:BCX1298
CAS No.:125708-06-7
- Xylopine
Catalog No.:BCX1299
CAS No.:517-71-5
Identification of alpha-Glucosidase Inhibitors from Scutellaria edelbergii: ESI-LC-MS and Computational Approach.[Pubmed:35209111]
Molecules. 2022 Feb 16;27(4):1322.
The recent study investigated the in vitro anti-diabetic impact of the crude extract (MeOH) and subfractions ethyl acetate (EtOAc); chloroform; n-butanol; n-hexane; and aqueous fraction of S. edelbergii and processed the active EtOAc fraction for the identification of chemical constituents for the first time via ESI-LC-MS analysis through positive ionization mode (PIM) and negative ionization mode (NIM); the identified compounds were further validated through computational analysis via standard approaches. The crude extract and subfractions presented appreciable activity against the alpha-glucosidase inhibitory assay. However, the EtOAc fraction with IC(50) = 0.14 +/- 0.06 microg/mL revealed the maximum potential among the fractions used, followed by the MeOH and n-hexane extract with IC(50) = 1.47 +/- 0.14 and 2.18 +/- 0.30 microg/mL, respectively. Moreover, the acarbose showed an IC(50) = 377.26 +/- 1.20 microg/ mL whereas the least inhibition was observed for the chloroform fraction, with an IC(50) = 23.97 +/- 0.14 microg/mL. Due to the significance of the EtOAc fraction, when profiled for its chemical constituents, it presented 16 compounds among which the flavonoid class was dominant, and offered eight compounds, of which six were identified in NIM, and two compounds in PIM. Moreover, five terpenoids were identified-three and two in NIM and PIM, respectively-as well as two alkaloids, both of which were detected in PIM. The EtOAc fraction also contained one phenol that was noticed in PIM. The detected flavonoids, terpenoids, alkaloids, and phenols are well-known for their diverse biomedical applications. The potent EtOAc fraction was submitted to computational analysis for further validation of alpha-glucosidase significance to profile the responsible compounds. The pharmacokinetic estimations and protein-ligand molecular docking results with the support of molecular dynamic simulation trajectories at 100 ns suggested that two bioactive compounds-Dihydrocatalpol and leucosceptoside A-from the EtOAc fraction presented excellent drug-like properties and stable conformations; hence, these bioactive compounds could be potential inhibitors of alpha-glucosidase enzyme based on intermolecular interactions with significant residues, docking score, and binding free energy estimation. The stated findings reflect that S. edelbergii is a rich source of bioactive compounds offering potential cures for diabetes mellitus; in particular, Dihydrocatalpol and leucosceptoside A could be excellent therapeutic options for the progress of novel drugs to overcome diabetes mellitus.
[Absorption and pharmacokinetics of radix rehmanniae in rats].[Pubmed:24358782]
Yao Xue Xue Bao. 2013 Sep;48(9):1464-70.
In this paper, absorption and pharmacokinetic study of Radix Rehmanniae was studied by liquid chromatography coupled with mass spectrometry method after oral administration to rats. By comparing the chromatograms of ultraviolet, full scan, extracted ion and selective reaction monitoring (SRM) of standard solution, Radix Rehmanniae, blank plasma and rat plasma post drug administration, catalpol and ajugol were found to be the main compounds absorbed from Radix Rehmanniae. Plasma concentrations of aucubin, Dihydrocatalpol, rehmannioside A (or rehmannioside B/ melittoside) and rehmannioside D were very low. Quantitative method for catalpol and aucubin and semi-quantitative method for other compounds in rat plasma were established. The pharmacokinetic study of those absorbed components was conducted after oral administration of 6 g x kg(-1) Radix Rehmanniae water extract to rats. Cmax, t(1/2) and AUC(0-infinity) of catalpol and ajugol were (2349.05 +/- 1438.34) and (104.25 +/- 82.05) ng x mL(-1), (0.86 +/- 0.32) and (0.96 +/- 0.37) h, (4407.58 +/- 2734.89) and (226.66 +/- 188.38) ng x h x mL(-1), respectively. tmax was at 1.00 h for catalpol and ajugol. Both catalpol and ajugol were absorbed and excreted rapidly.
Two new iridoid glucosides from Picrorhiza scrophulariiflora.[Pubmed:16864432]
J Asian Nat Prod Res. 2006 Apr-May;8(3):259-63.
Two new iridoid glucosides with 3,4-Dihydrocatalpol skeleton, piscrosides A (1) and B (2) together with nine known iridoid glucosides and three known cucurbitacin glucosides, were isolated from the stems of Picrorhiza scrophulariiflora. Their structures were established by MS, 1H NMR, 13C NMR and 2D NMR methods (including HSQC, HMBC and NOESY experiments).